JP2024161376A5 - - Google Patents

Download PDF

Info

Publication number
JP2024161376A5
JP2024161376A5 JP2024114477A JP2024114477A JP2024161376A5 JP 2024161376 A5 JP2024161376 A5 JP 2024161376A5 JP 2024114477 A JP2024114477 A JP 2024114477A JP 2024114477 A JP2024114477 A JP 2024114477A JP 2024161376 A5 JP2024161376 A5 JP 2024161376A5
Authority
JP
Japan
Prior art keywords
drawings
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024114477A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024161376A (ja
Filing date
Publication date
Priority claimed from PCT/US2019/018335 external-priority patent/WO2019161290A1/en
Application filed filed Critical
Publication of JP2024161376A publication Critical patent/JP2024161376A/ja
Publication of JP2024161376A5 publication Critical patent/JP2024161376A5/ja
Pending legal-status Critical Current

Links

JP2024114477A 2018-02-15 2024-07-18 真核ゲノム修飾のための操作されたCas9システム Pending JP2024161376A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201862631304P 2018-02-15 2018-02-15
US62/631,304 2018-02-15
US201862720525P 2018-08-21 2018-08-21
US62/720,525 2018-08-21
PCT/US2019/018335 WO2019161290A1 (en) 2018-02-15 2019-02-15 Engineered cas9 systems for eukaryotic genome modification
JP2020531575A JP7109547B2 (ja) 2018-02-15 2019-02-15 真核ゲノム修飾のための操作されたCas9システム
JP2022083820A JP7559005B2 (ja) 2018-02-15 2022-05-23 真核ゲノム修飾のための操作されたCas9システム

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2022083820A Division JP7559005B2 (ja) 2018-02-15 2022-05-23 真核ゲノム修飾のための操作されたCas9システム

Publications (2)

Publication Number Publication Date
JP2024161376A JP2024161376A (ja) 2024-11-19
JP2024161376A5 true JP2024161376A5 (cg-RX-API-DMAC7.html) 2025-01-14

Family

ID=65995829

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2020531575A Active JP7109547B2 (ja) 2018-02-15 2019-02-15 真核ゲノム修飾のための操作されたCas9システム
JP2022083820A Active JP7559005B2 (ja) 2018-02-15 2022-05-23 真核ゲノム修飾のための操作されたCas9システム
JP2024114477A Pending JP2024161376A (ja) 2018-02-15 2024-07-18 真核ゲノム修飾のための操作されたCas9システム

Family Applications Before (2)

Application Number Title Priority Date Filing Date
JP2020531575A Active JP7109547B2 (ja) 2018-02-15 2019-02-15 真核ゲノム修飾のための操作されたCas9システム
JP2022083820A Active JP7559005B2 (ja) 2018-02-15 2022-05-23 真核ゲノム修飾のための操作されたCas9システム

Country Status (11)

Country Link
US (2) US10767193B2 (cg-RX-API-DMAC7.html)
EP (1) EP3752607A1 (cg-RX-API-DMAC7.html)
JP (3) JP7109547B2 (cg-RX-API-DMAC7.html)
KR (3) KR102465067B1 (cg-RX-API-DMAC7.html)
CN (1) CN111902536B (cg-RX-API-DMAC7.html)
AU (3) AU2019222568B2 (cg-RX-API-DMAC7.html)
BR (1) BR112020010479A2 (cg-RX-API-DMAC7.html)
CA (2) CA3281020A1 (cg-RX-API-DMAC7.html)
IL (2) IL321024A (cg-RX-API-DMAC7.html)
SG (1) SG11202007382TA (cg-RX-API-DMAC7.html)
WO (1) WO2019161290A1 (cg-RX-API-DMAC7.html)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3204496A1 (en) 2014-10-10 2017-08-16 Editas Medicine, Inc. Compositions and methods for promoting homology directed repair
US11111492B2 (en) * 2017-03-06 2021-09-07 Florida State University Research Foundation, Inc. Genome engineering methods using a cytosine-specific Cas9
CN112654710A (zh) 2018-05-16 2021-04-13 辛瑟高公司 用于指导rna设计和使用的方法和系统
AU2019291918B2 (en) 2018-06-29 2025-06-12 Editas Medicine, Inc. Synthetic guide molecules, compositions and methods relating thereto
US10913941B2 (en) 2019-02-14 2021-02-09 Metagenomi Ip Technologies, Llc Enzymes with RuvC domains
SG11202108812SA (en) 2019-02-15 2021-09-29 Sigma Aldrich Co Llc Crispr/cas fusion proteins and systems
EP4219700A1 (en) 2019-03-07 2023-08-02 The Regents of the University of California Crispr-cas effector polypeptides and methods of use thereof
JP7785002B2 (ja) 2019-11-05 2025-12-12 ペアーワイズ プランツ サービシズ, インコーポレイテッド 対立遺伝子のrnaにコードされたdnaの置換のための組成物および方法
KR20220116512A (ko) 2019-12-17 2022-08-23 시그마-알드리치 컴퍼니., 엘엘씨 박테로이데스의 게놈편집
GB2617659B (en) * 2020-02-14 2024-05-01 Metagenomi Inc Enzymes with RuvC domains
CA3177051A1 (en) * 2020-03-31 2021-10-07 Metagenomi, Inc. Class ii, type ii crispr systems
CN112159801B (zh) * 2020-07-13 2022-11-15 复旦大学 SlugCas9-HF蛋白、含有SlugCas9-HF蛋白的基因编辑系统及应用
KR102679001B1 (ko) * 2020-09-21 2024-06-28 고려대학교 산학협력단 신규의 개량된 염기 편집 또는 교정용 융합단백질 및 이의 용도
AU2021374974A1 (en) * 2020-11-06 2023-05-25 Pairwise Plants Services, Inc. Compositions and methods for rna-encoded dna-replacement of alleles
CN119452085A (zh) 2021-08-27 2025-02-14 宏基因组学公司 具有ruvc结构域的酶
CN113717960B (zh) * 2021-08-27 2023-07-18 电子科技大学 一种新Cas9蛋白、CRISPR-Cas9基因组定向编辑载体及基因组编辑方法
KR20240110603A (ko) 2021-11-24 2024-07-15 메타지노미, 인크. 엔도뉴클레아제 시스템
CN114657181B (zh) * 2022-04-01 2023-08-25 安徽大学 一种靶向H1.4的sgRNA以及H1.4基因编辑方法
EP4592322A4 (en) * 2022-09-23 2026-08-05 Chuang Woei Jer Fusion protein targeting alpha(IIB)beta3 integrin and containing a tissue plasminogen activator or a variant thereof, and its use

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030232430A1 (en) 2001-11-26 2003-12-18 Advanced Cell Technology Methods for making and using reprogrammed human somatic cell nuclei and autologous and isogenic human stem cells
ES2728782T3 (es) 2012-05-25 2019-10-28 Univ California Métodos y composiciones para la modificación de ADN objetivo dirigida por ARN y para la modulación de la transcripción dirigida por ARN
DK3363902T3 (da) 2012-12-06 2020-01-02 Sigma Aldrich Co Llc Crispr-baseret genommodifikation og -regulering
KR102955556B1 (ko) * 2012-12-12 2026-04-22 더 브로드 인스티튜트, 인코퍼레이티드 서열 조작을 위한 crispr-cas 성분 시스템, 방법 및 조성물
WO2014197748A2 (en) 2013-06-05 2014-12-11 Duke University Rna-guided gene editing and gene regulation
US9074199B1 (en) * 2013-11-19 2015-07-07 President And Fellows Of Harvard College Mutant Cas9 proteins
EP3097212A4 (en) * 2014-01-24 2017-10-04 North Carolina State University Methods and compositions for sequences guiding cas9 targeting
EP3981876A1 (en) * 2014-03-26 2022-04-13 Editas Medicine, Inc. Crispr/cas-related methods and compositions for treating sickle cell disease
US10450584B2 (en) * 2014-08-28 2019-10-22 North Carolina State University Cas9 proteins and guiding features for DNA targeting and genome editing
EP3845655B1 (en) * 2014-10-01 2025-01-01 The General Hospital Corporation Methods for increasing efficiency of nuclease-induced homology-directed repair
DK3604527T3 (da) 2016-06-02 2021-05-31 Sigma Aldrich Co Llc Anvendelse af programmerbare dna-bindingsproteiner til at forbedre målrettet genommodifikation
CN109688820B (zh) 2016-06-24 2023-01-10 科罗拉多州立大学董事会(法人团体) 用于生成条形码化组合文库的方法
EP4650364A3 (en) 2016-07-06 2026-01-21 Vertex Pharmaceuticals Incorporated Materials and methods for treatment of pain related disorders
US11242513B2 (en) * 2016-12-14 2022-02-08 Wageningen Universiteit Thermostable Cas9 nucleases
KR102655021B1 (ko) * 2017-07-11 2024-04-04 시그마-알드리치 컴퍼니., 엘엘씨 표적된 게놈 변형을 개선하기 위한 뉴클레오솜 상호작용 단백질 도메인 사용
CA3071769A1 (en) 2017-07-31 2019-02-07 Reflection Biotechnologies Limited Cellular models of and therapies for ocular diseases

Similar Documents

Publication Publication Date Title
JP2024116190A5 (cg-RX-API-DMAC7.html)
JP2024114921A5 (cg-RX-API-DMAC7.html)
JP2023171775A5 (cg-RX-API-DMAC7.html)
JP2022184985A5 (cg-RX-API-DMAC7.html)
JP2023166402A5 (cg-RX-API-DMAC7.html)
JP2023103258A5 (cg-RX-API-DMAC7.html)
JP2025176106A5 (cg-RX-API-DMAC7.html)
JP2025138632A5 (cg-RX-API-DMAC7.html)
JP2024036694A5 (cg-RX-API-DMAC7.html)
JP2024032941A5 (cg-RX-API-DMAC7.html)
JP2023145572A5 (cg-RX-API-DMAC7.html)
JP2023518821A5 (cg-RX-API-DMAC7.html)
JP2025138641A5 (cg-RX-API-DMAC7.html)
JP2022543046A5 (cg-RX-API-DMAC7.html)
JP2025069142A5 (cg-RX-API-DMAC7.html)
JP2024150466A5 (cg-RX-API-DMAC7.html)
JP2023181322A5 (cg-RX-API-DMAC7.html)
JP2025084821A5 (cg-RX-API-DMAC7.html)
JP2025098156A5 (cg-RX-API-DMAC7.html)
JP2025118629A5 (cg-RX-API-DMAC7.html)
JP2024149687A5 (cg-RX-API-DMAC7.html)
JP2024045126A5 (cg-RX-API-DMAC7.html)
JP2024099585A5 (cg-RX-API-DMAC7.html)
JP2025090801A5 (cg-RX-API-DMAC7.html)
JP2025094038A5 (cg-RX-API-DMAC7.html)